APA (7th ed.) Citation

Scott, I. U., VanVeldhuisen, P. C., Oden, N. L., Ip, M. S., & Blodi, B. A. (2022). Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion. American journal of ophthalmology, 240, 330-341. https://doi.org/10.1016/j.ajo.2022.04.001

Chicago Style (17th ed.) Citation

Scott, Ingrid U., Paul C. VanVeldhuisen, Neal L. Oden, Michael S. Ip, and Barbara A. Blodi. "Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion." American Journal of Ophthalmology 240 (2022): 330-341. https://doi.org/10.1016/j.ajo.2022.04.001.

MLA (9th ed.) Citation

Scott, Ingrid U., et al. "Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion." American Journal of Ophthalmology, vol. 240, 2022, pp. 330-341, https://doi.org/10.1016/j.ajo.2022.04.001.